Form 8-K - Current report:
SEC Accession No. 0001829126-25-008140
Filing Date
2025-10-15
Accepted
2025-10-15 16:58:30
Documents
14
Period of Report
2025-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintech_8k.htm   iXBRL 8-K 35270
2 EXHIBIT 5.1 nexalintech_ex5-1.htm EX-5.1 10425
3 EXHIBIT 10.1 nexalintech_ex10-1.htm EX-10.1 22942
  Complete submission text file 0001829126-25-008140.txt   245626

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20251015.xsd EX-101.SCH 2984
5 XBRL LABEL FILE nxl-20251015_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nxl-20251015_pre.xml EX-101.PRE 22339
16 EXTRACTED XBRL INSTANCE DOCUMENT nexalintech_8k_htm.xml XML 3764
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 251395491
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)